中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Primary Ovarian Insufficiency, Polycystic Ovary Syndrome & the CardiOvascular Risk Profile

只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
状态已完成
赞助商
UMC Utrecht
合作者
VU University Medical Center
Erasmus Medical Center

关键词

抽象

The polycystic ovary syndrome (PCOS) is the most common endocrinopathy amongst women of reproductive age. PCOS is associated with various cardiovascular risk factors such as obesity, glucose intolerance, dyslipidemia hypertension and the metabolic syndrome. Whether these increased cardiovascular risk factors result in the development of actual cardiovascular disease in later life remains to be established.
Women with premature ovarian insufficiency (POI), experience menopause prior to the age of 40 years. Women with POI may exhibit dyslipidemia. A young age at menopause has been previously associated with increased cardiovascular morbidity and mortality.

描述

Cardiovascular risk profile will be assessed in women with PCOS and POI > 45 years of age, consisting of:

fasting serum and urine analyses blood pressure, length, weight, waist circumference, hip circumference ECG carotid intima media thickness cardiac ultrasound

spare serum, plasma and urine will be stored in -80 degrees celsius biobank.

日期

最后验证: 11/30/2018
首次提交: 11/19/2015
提交的预估入学人数: 11/23/2015
首次发布: 11/29/2015
上次提交的更新: 12/09/2018
最近更新发布: 12/10/2018
实际学习开始日期: 06/30/2013
预计主要完成日期: 11/30/2017
预计完成日期: 11/30/2017

状况或疾病

Cardiovascular Diseases

干预/治疗

Procedure: cardiovascular screening

-

手臂组

干预/治疗
PCOS
Rotterdam criteria (at least 2 out of three criteria present) oligo-anovulation polycystic ovarian morphology hyperandrogenism
POI
amenorrhea of at least 4 months prior to age 40 years, with follicle stimulating hormone (FSH) levels above 40 IU/L

资格标准

有资格学习的年龄 45 Years 至 45 Years
有资格学习的性别Female
取样方式Probability Sample
接受健康志愿者
标准

Inclusion Criteria:

- age above 45 years

Exclusion Criteria:

- none

结果

主要结果指标

1. carotid intima media thickness [10 years post diagnosis]

ultrasound measurement of thickness of carotid wall (mean IMT), presence of atherosclerotic plaques (yes/no, location)

次要成果指标

1. dyslipidemia [10 years post diagnosis]

serum measurement of low density lipoprotein cholesterol, triglycerides, total cholesterol, high density lipoprotein cholesterol

2. insulin and glucose levels [10 years post diagnosis]

3. C-reactive protein [10 years post diagnosis]

4. homocysteine [10 years post diagnosis]

5. uric acid [10 years post diagnosis]

6. androgen levels [10 years post diagnosis]

7. electrocardiogram (ECG) [10 years post diagnosis]

documentation of heart rythm, potential signs of ischemia (ST segment), length PR, QRS, QT, RR interval

8. cardiac ultrasound (hypertrophy) [10 years post diagnosis]

measurement of left ventricular ejection fraction and left ventricular mass,

加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge